NL-OMON29626已完成不适用
Generation of circulating tumor cell derived organoidsthrough enrichment by leukapheresis - A novel drug screening system in metastatic prostate cancer
Eramus Medical Center Rotterdam0 个研究点目标入组 46 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 46
研究概览
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Metastatic prostate cancer.
- •- Intention to start (new) line of systemic treatment.
排除标准
- •- Low CTC count.
- •- Patients with a known hypersensitivity to the used LA-anticoagulant (ACD).
研究者
相似试验
招募中
不适用
Generation of circulating tumor cell derived organoids through enrichment by leukapheresis - A novel drug screening system in metastatic prostate cancerprostate cancerNL-OMON46104Erasmus MC, Universitair Medisch Centrum Rotterdam79
已完成
不适用
Characterization of Circulating Tumor Cells (CTC-s) in Patients With Locally Advanced or Metastatic Stage IV Breast CancerLocally Advanced Breast CancerMetastatic (Stage IV) Breast CancerStage III-IV Breast Cancer or InflammatoryNCT01048918City of Hope Medical Center280
已完成
不适用
Circulating Tumor Cells in Solid TumorsSolid Tumor, AdultNCT03161821UNC Lineberger Comprehensive Cancer Center206
Unknown
不适用
Cultured Circulating Tumor Cells in Prostate and Other CancersProstate CancerNCT02123862Oscar Goodman, Jr.220
已完成
不适用
Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation TherapyCirculating Tumor CellsNCT02449837UNC Lineberger Comprehensive Cancer Center162